Unplanned reoperation after radical surgery for oral cancer：an analysis of risk factors and outcomes

doi:10.21203/rs.3.rs-1496659/v1

Background: Unplanned reoperation (UR) after radical surgery for oral cancer (OC) is a health threat for the patients. At present, the predictive factors for the UR effect are still debatable. The aim of the study was to understand the risk factors for unplanned reoperation after surgery, and to explore a potential role for long-term survival.

Methods: Univariate and multivariate analyses were used to identify risk factors for demographic and clinical characteristics of patients. The data was analyzed statistically between November and December 2021.

Results: The incidence of UR was 15.7%. The primary cause of UR was reconstructed flap complications. Multivariate logistic regression analyses revealed that diabetes, tumor size, type of reconstruction, and nodal metastasis were independent risk factors for UR. Patients undergoing UR had a longer hospitalization, more post-operative complications, and a higher mortality compared with the non-UR group. UR is negatively correlated with the cancer-specific survival rate of patients (Log-rank test, P = 0.024).

Conclusion: Diabetes, tumor size, pedicled flap reconstruction and cervical nodal metastasis (N2) as independent risk factors for UR was discovered. UR was positively correlated with perioperative complications prolong hospital stay, and increased early mortality, but negatively correlated with the cancer-specific survival rate survival rate.

oral cancer

surgery

unplanned reoperation

outcomes

Oral cancer (OC) ranks as the sixth most common carcinoma, and it’s a matter of global concern[1]. The higher prevalence and mortality of oral cancer have been reported in developing countries, and China has been perceived as a high incidence of oral cancer[1, 2]. Surgery is considered to be the most effective modalities for the treatment of oral cancer patients[3]. Despite continuing improvements in surgical methods, reducing the complications and improving long-term survival remains a concern. Due to the intricacy of the surgery, postoperative 30-day complication rates for oral cancer can be as high as 20.3%[4]. Approximately 10% of patients with these complications require reoperation[4].

Unplanned reoperations have been extensively researched in a variety of surgical fields[5–8]. Several studies examined the risk factors of unplanned reoperation for head and neck cancer surgery complications. Choi et al. showed that long operation time, previous treatment, and higher N (N2) classification were considered key risk factors for unplanned reoperation[9]. According to Zhao et al.’s study, the leading cause of UR were postoperative bleeding, vascular crisis, and diagnostic issues, and patients with microvascular flaps or malignant tumors[10]. Up to now, far too little attention has been paid to assessing the incidence and risk factors associated with UR for oral cancer. To our knowledge, no previous study has given sufficient consideration to the impact of UR on long-term survival after radical oral cancer surgery. Thus, there is a great need to understand the relationship between UR and cancer prognosis.

The aim of our research was to further assess the risk factors for UR after radical oral cancer surgery, and validate a possible correlation between UR and long-term survival. The result from the study may increase the attention of UR among clinicians and reduce the incidences of postoperative complications after surgery.

Materials and Methods

A retrospective analysis was done on oral cancer patients treated with radical oral cancer surgery in the Department of Oral and Maxillofacial Surgery, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University. 506 patients undergoing radical surgery for OC between February 2014 and November 2019 were included. The exclusion criteria were as follows: 1) maxillofacial salivary cancer patients, leaving oral cavity cancer patients (n = 30); 2) patients who did not receive neck dissection (n = 27); 3) patients who received radiotherapy and chemotherapy before surgery (n = 28). Together, 421 patients were enrolled for further analysis. According to postoperative assessment, 66 patients were assigned to the UR group, and 355 patients were termed the non-UR group (Figure 1). All patients were followed for up to 2 years. We strictly followed 1975 Declaration of Helsinki ethical guidelines. This study was approved by the ethical review board of The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University.

Data collection and definitions

Basic information on patients, body mass index (BMI), medical history, surgical procedures, postoperative complications, and the annual follow-up data were derived from the medical record database of The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University. OC was diagnosed according to histopathological evaluation, and the histological grade was staged according to the AJCC-TNM staging[11]. UR refers to the status that the occurrence of re-operation follow-up 30 days after surgery due to complications caused by oral cancer surgery. The cancer survival rate was defined as the time from the first day of treatment performed to death.

Operative techniques

Experienced surgeons perform all operations in oral and maxillofacial surgery at our center. At least 50 radical surgeries for oral cancer have been performed by surgeons. The operation method was decided using a risk-adapted approach based on tumor location and size, according to the treatment principle for oral cancer[12, 13]. Free or pedicled flaps were adopted for large postoperative defects' reconstruction after surgery: submental island flap, forearm flap, fibula flap, and anterolateral thigh flap.

Follow-up

A flow chart presenting patient selection is displayed in Figure 1. Follow-up data were collected from all patients who survived the UR procedure (n = 66), and 355 patients in the non-UR group. Telephone follow-up, medical records, visiting, or outpatient/inpatient clinic visits were used to collect follow-up data. The deadline for follow-up was December 31, 2021.

Statistical analysis

Univariable and multivariable analysis were used to evaluate clinical factors for unplanned reoperation. Categorical data were analyzed by Chi-square test or Fisher’s exact test. Continuous data were compared with the Mann–Whitney U test. A multivariate Cox regression analysis and Kaplan–Meier analysis were utilized to assess recurrence-free and overall survival of UR. All data analyses were performed with the SPSS (IBM SPSS 22.0, SPSS Inc). Statistical tests were two sided and considered significant with a P-value<0.05.

Clinical variables between UR group and non-UR group

421 patients were enrolled in the study, included 227 males and 194 females. The mean age was 65.0 ± 8.0 years, 66cases (mean age: 71.1 ± 10.1 years) underwent UR, including 41 males and 25 females. The incidence of UR was 15.7% (66/421). The leading cause of unplanned reoperation was reconstruction flap related complications (32/66, 48.5%), followed by bleeding (9/66, 13.6%), necrosis (7/66, 10.6%), infection (6/66, 9.1%), fistula (2/66, 3.0%), and flap donor site complications (2/66, 3.0%) (Table 1). Gender, age, smoking, drinking, BMI, preoperative anemia, tumor size and cervical node metastasis did not show a significant difference in UR group and non-UR group. Early tumor (T1-T2) and no lymph node metastases (N0) were the most common cancer types in the UR group (86.4% and 75.8%, respectively) and the non-UR group (88.2% and 83.4%, respectively) (Table 2).

Furthermore, the multivariate analysis showed that diabetes (OR = 2.544, 95%CI = 1.257–5.128, P = 0.009), tumor size (OR = 1.879, 95%CI = 1.038–3.401, P = 0.037), N classification (N2, OR = 3.076, 95%CI = 1.526–6.211, P = 0.002) and type of reconstruction (pedicled flap reconstruction, OR = 0.491, 95%CI = 0.259-0.931, P = 0.029) were independent risk factors for unplanned reoperation in OC patients (Table 3).

Early surgical outcomes of the UR patients

The incidence of postoperative complications after surgery were 77.3% (51/66) in UR group while the incidence for non-UR group was 6.5% (23/355), including reconstructed flap complications, infection, bleeding, fistula, flap donor site complication and necrosis. Additionally, lengths of stay in the UR group had a significantly increased compared with the non-UR group (23.78 ± 0.82 vs 13.24 ± 0.32 days, P < 0.001) (Table 4).

UR as a prognostic factor for long-term survival

In the survival analysis of OC patient prognosis, the mean follow-up time was 53 months. According to the univariate survival analyses, unplanned reoperation, type of reconstruction, age, diabetes, preoperative anemia, tumor size, and cervical nodal metastasis may be predictive factors for recurrence-free survival (Table 5). Furthermore, the results of multivariate logistic regression analysis showed that age (HR = 3.077, 95%CI = 1.664–5.682, P < 0.01), diabetes (HR = 1.833, 95%CI = 1.091–3.257, P = 0.02), N classification(N1, HR = 4.464, 95%CI = 2.551–7.813, P < 0.01) (N2, HR = 2.315, 95%CI = 1.101–4.878, P = 0.03), type of reconstruction(Pedicled flap, HR = 0.413, 95%CI = 0.236-0.722, P = 0.02) (free flap, HR = 0.354, 95%CI = 0.148-0.801, P = 0.01), and unplanned reoperation (HR = 2.864, 95%CI = 1.181–7.401, P = 0.02) were independent predictors of outcome (Table 5). UR was significantly associated with shortened cancer-specific survival in this study (Log-rank test, P = 0.024) (Figure 2).

Over the last dozen years, the incidence of UR has decreased with the advances in surgical technique. Nevertheless, the poor prognosis among patients with UR remains a serious threat to global health. UR often is associated with higher postoperative morbidity, mortality and consequent high medical costs[14, 15]. In the current medical and health institutions, the UR rates was recognized as one of the evaluation indicators of surgical quality, attracting the attention of clinicians[6]. According to Choi et al’s study, the incidence of unplanned reoperation in head and neck cancer surgery was 10.5%[9]. Zhao et al reported that the overall unplanned reoperation rate in oral and maxillofacial surgery was 1.52%[10]. The incidence of UR was found to be 15.7 percent in this study, which enrolled over 400 patients. UR is typically correlated with complex surgical procedures such as radical surgery of oral cancer. To further lower risk factors and indications for UR, it is meaningful for surgeons to understand preoperative, perioperative, and postoperative risk factors. Meanwhile, we found that diabetes, tumor size, N classification (N2), and pedicled flap reconstruction were independent risk factors for UR.

Flap failure was the most dominant cause of unplanned reoperations in our study. Thomas’s comparative study showed a reoperation rate of 20.2% in the head and neck free flap reconstructions[16]. Recently, Kwok and Agarwal had investigated the reoperation rate of all microvascular free tissue transfers, and showed the overall reoperation rate was 12.9% and a head and neck reoperation rate was 18.0%[17]. Blockage of blood arteries owing to thrombus development was discovered to be a major cause of flap failure[18]. Anastomosis of a secondary vein has been proven beneficial to the survival of the flap and reduces venous congestion[18]. However, microscopic vascular anastomoses required enormous amounts of time to expend. Moreover, multiple studies showed that a single venous anastomosis can provide enough drainage while maintaining flap survival and reducing operation time, with no significant difference compared to two venous anastomosis[19, 20]. To prevent venous thrombosis, Matti Sievert et al. suggested that low molecular weight heparin can effectively improve the survival rate of the flap[21]. The above literature showed that one venous anastomosis combined with low molecular weight heparin applied could be attributed to an increased survival rate of flap.

Previous studies have found that postoperative bleeding is the most common reason for unplanned reoperation for a variety of diseases, including maxillofacial surgery[22–24]. Our data revealed that postoperative bleeding was the second most common complication after radical oral cancer surgery. There were only 9 cases of postoperative hemorrhage in UR group, accounting for nearly 13.6 percent of the total number of UR patients. Early postoperative bleeding is associated with hemostasis failure or coagulation defects[10]. Taking NSAIDS and hypertension together is a common cause of postoperative bleeding.[25, 26] In our opinion, preoperative coagulopathy should be given particular attention, and blood pressure should be maintained normal in individuals. Moreover, controlling hemostasis and blood pressure under anesthesia is critical intraoperatively[27]. In this study, delayed hemorrhages were more common in tiny arteries and muscle or connective tissue in the surgical area. To prevent hemostasis, an electrical knife has been widely used in a variety of surgical specialties. Zhao et al. considered that the postoperative bleeding was caused by inappropriate use of the electrical knife[10]. Electrical knives with a high frequency should stay in the tissue for a long enough time to establish effective hemostasis. The ultrasonic scalpel can be effective for providing a relative bloodless field in muscle or connective tissue, which facilitates saving surgical time[28]. Persistent postoperative pain promotes high blood pressure, which also leads to arrhythmia or small blood vessel hemorrhage. Sufficient postoperative analgesia is more conducive to reducing the risk of UR.

Marra et al. found that extra-nodal extension and perineural invasion are prognostic factors associated with reduced disease-free survival for oral tongue cancer[29]. Hussain et al. showed that nodal stage was the most important poor prognostic factor in terms of disease-free survival in T1, T2 oral tongue cancer[30]. Our research showed that UR may have a significant impact on oral cancer patients' long-term survival rates following surgery. In addition, multivariate analyses revealed that unplanned reoperation may be poor prognostic factors for cancer-specific survival.

Despite our efforts to subject it to a comprehensive analysis, the present study still has a few limitations. First, our study was based on retrospective single-center study. Further prospective multicenter studies may be warranted to further validate the findings. Second, the relatively small sample size of UR should be taken into consideration. Third, due to the complex condition of patients, different clinical decision-making for the same disease might affect our results. Therefore, a more comprehensive investigation is needed for further confirmation in the context of big data. Despite these limitations, the research confirmed the clinical importance of an unplanned reoperation in oral cancer surgery.

This study suggests that tumor size, diabetes, N classification (N2), and pedicled flap reconstruction might be risk factors for UR after oral cancer radical surgery. UR was associated with worse long-term survival, and may be a novel prognostic factor for OC patients. These findings may help identify high-risk patients for UR, optimize surgical planning, strengthen perioperative management, and reduce the incidence of unplanned reoperations.

UR: Unplanned reoperation; OC: oral cancer; BMI: body mass index.

Acknowledgements

Not applicable.

Authors’ contributions

PY conceived the study, carried out the design and coordination, wrote the manuscript, and gave the final approval of the version to be submitted. MW and HZ critically revised the manuscript for important intellectual content. WZ and PY collected the clinical data and drafted the article. All authors read and approved the final manuscript.

Acknowledgements

The authors thank all the volunteers for participating in the study.

Funding

This study did not receive any funding and there are no financial conflicts of interest.

Availability of data and materials

The data are available from the corresponding author on reasonable request.

Ethics approval and consent to participate

All participants gave written informed consent. This study was conducted according to the Declaration of Helsinki and was approved by the Institutional Ethics Committee of the Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University.

Consent to publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Warnakulasuriya S: Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol2010, 46(6):407-410.
Shrestha AD, Vedsted P, Kallestrup P, Neupane D: Prevalence and incidence of oral cancer in low- and middle-income countries: A scoping review. Eur J Cancer Care (Engl)2020, 29(2):e13207.
Wong T, Wiesenfeld D: Oral Cancer. Aust Dent J2018, 63 Suppl 1:S91-S99.
Schwam ZG, Sosa JA, Roman S, Judson BL: Complications and mortality following surgery for oral cavity cancer: Analysis of 408 cases. The Laryngoscope2015, 125(8):1869-1873.
Zuo X, Cai J, Chen Z, Zhang Y, Wu J, Wu L, Wang J: Unplanned reoperation after radical gastrectomy for gastric cancer: causes, risk factors, and long-term prognostic influence. Ther Clin Risk Manag2018, 14:965-972.
Sangal NR, Nishimori K, Zhao E, Siddiqui SH, Baredes S, Chan Woo Park R: Understanding Risk Factors Associated With Unplanned Reoperation in Major Head and Neck Surgery. JAMA otolaryngology-- head & neck surgery2018, 144(11):1044-1051.
Program of Randomized Trials to Evaluate Pre-operative Antiseptic Skin Solutions in Orthopaedic Trauma I, Slobogean GP, Sprague S, Wells J, Bhandari M, Rojas A, Garibaldi A, Wood A, Howe A, Harris ADet al: Effectiveness of Iodophor vs Chlorhexidine Solutions for Surgical Site Infections and Unplanned Reoperations for Patients Who Underwent Fracture Repair: The PREP-IT Master Protocol. JAMA Netw Open2020, 3(4):e202215.
Kazaure HS, Chandra V, Mell MW: Unplanned reoperations after vascular surgery. J Vasc Surg2016, 63(3):730-736.
Choi N, Park SI, Kim H, Sohn I, Jeong HS: The impact of unplanned reoperations in head and neck cancer surgery on survival. Oral Oncol2018, 83:38-45.
Zhao Z, Hao J, He Q, Deng R: Unplanned Reoperations in Oral and Maxillofacial Surgery. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons2019, 77(1):135 e131-135 e135.
Huang SH, O'Sullivan B: Overview of the 8th Edition TNM Classification for Head and Neck Cancer. Curr Treat Options Oncol2017, 18(7):40.
Bulsara VM, Worthington HV, Glenny A-M, Clarkson JE, Conway DI, Macluskey M: Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. Cochrane Database Syst Rev2018, 12:CD006205.
Kerawala C, Roques T, Jeannon JP, Bisase B: Oral cavity and lip cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol2016, 130(S2):S83-S89.
Palmer SJ, Parker MJ, Hollingworth W: The cost and implications of reoperation after surgery for fracture of the hip. J Bone Joint Surg Br2000, 82(6):864-866.
Kroon HM, Breslau PJ, Lardenoye JWHP: Can the incidence of unplanned reoperations be used as an indicator of quality of care in surgery? Am J Med Qual2007, 22(3):198-202.
Thomas WW, Brant J, Chen J, Coblens O, Fischer JP, Newman JG, Chalian AA, Shanti RM, Cannady SB: Clinical Factors Associated With Reoperation and Prolonged Length of Stay in Free Tissue Transfer to Oncologic Head and Neck Defects. JAMA Facial Plast Surg2018, 20(2):154-159.
Kwok AC, Agarwal JP: Unplanned reoperations after microvascular free tissue transfer: An analysis of 2,244 patients using the american college of surgeons national surgical quality improvement program database. Microsurgery2017, 37(3):184-189.
Ahmadi I, Herle P, Rozen WM, Leong J: One versus two venous anastomoses in microsurgical free flaps: a meta-analysis. Journal of reconstructive microsurgery2014, 30(6):413-418.
Futran ND, Stack BC, Jr.: Single versus dual venous drainage of the radial forearm free flap. American journal of otolaryngology1996, 17(2):112-117.
Dodd SX, Morzycki A, Nickel KJ, Campbell S, Guilfoyle R: One or two venous pedicles by anastomoses for free flaps in reconstruction of the lower extremity: A systematic review and meta-analysis. Microsurgery2021, 41(8):792-801.
Sievert M, Goncalves M, Tamse R, Mueller SK, Koch M, Gostian AO, Iro H, Scherl C: Postoperative management of antithrombotic medication in microvascular head and neck reconstruction: a comparative analysis of unfractionated and low-molecular-weight heparin. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies2021, 278(5):1567-1575.
Lyu HG, Sharma G, Brovman EY, Ejiofor J, Urman RD, Gold JS, Whang EE: Unplanned reoperation after hepatectomy: an analysis of risk factors and outcomes. HPB (Oxford)2018, 20(7):591-596.
Gangl O, Fröschl U, Hofer W, Huber J, Sautner T, Függer R: Unplanned reoperation and reintervention after pancreatic resections: an analysis of risk factors. World J Surg2011, 35(10):2306-2314.
Yang Y, Ma J, Lin Y, Wu X, Wang L, Wang A: Causes and affecting factors of unplanned reoperations in cancer patients. Zhonghua Zhong Liu Za Zhi2014, 36(7):546-548.
Li P, Luo R, Guo L, Li W, Qi J: Impact of the Body Mass Index on Hemorrhage After Surgery for Thyroid Cancer. Cancer management and research2020, 12:557-565.
Ono S, Kato M, Imai A, Yoshida T, Hirota J, Hata T, Takagi K, Kamada G, Ono Y, Nakagawa Met al: Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study. Journal of clinical biochemistry and nutrition2009, 45(2):248-253.
Algattas H, Kimmell KT, Vates GE: Risk of Reoperation for Hemorrhage in Patients After Craniotomy. World neurosurgery2016, 87:531-539.
Tirelli G, Del Piero GC, Perrino F: Ultracision Harmonic Scalpel in oral and oropharyngeal cancer resection. J Craniomaxillofac Surg2014, 42(5):544-547.
Marra A, Violati M, Broggio F, Codecà C, Blasi M, Luciani A, Zonato S, Rabbiosi D, Moneghini L, Saibene Aet al: Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2019, 39(2):84-91.
Hussain R, Jamshed A, Iqbal H, Usman S, Irfan M, Hafeez Bhatti AB: Long term survival and impact of various prognostic factors in T1, T2 oral tongue cancer in Pakistan. J Pak Med Assoc2016, 66(2):187-193.

Table 1

Causes of UR within 30 days in oral cancer surgery (n = 66)

Causes	No. (%)
Reconstructed flap complications	32(48.5)
Bleeding	9 (13.6)
Necrosis	7 (10.6)
Infection	6 (9.1)
Fistula	2 (3.0)
Flap donor site complications	2 (3.0)
Others	8 (12.2)

Abbreviations: UR, unplanned reoperation

Table 2

Univariate analysis of potential influencing factors for UR

Variables	Non-UR	UR	P-value
	Group (n, %)	Group (n, %)
Gender			0.1786
male	186 (52.4)	41 (62.1)
female	169 (47.6)	25 (37.9)
Age			0.7737
<60	111 (31.3)	22 (33.3)
≥60	244 (68.7)	44 (66.7)
Smoking			0.6661
No	318 (89.6)	58 (87.9)
Yes	37 (10.4)	8 (12.1)
Alcohol			0.6232
No	328 (92.4)	60 (90.9)
Yes	27 (7.6)	6 (9.1)
BMI (kg/m²)			0.5823
≤25	215 (60.6)	43 (65.2)
>25	140 (39.4)	23 (34.8)
Hypertension			0.0367*
No	262 (73.8)	40 (60.6)
Yes	93 (26.2)	26 (39.4)
Diabetes			0.0128*
No	318 (89.6)	51 (77.3)
Yes	37 (10.4)	15 (22.7)
Preoperative anemia
No	292 (82.3)	54 (81.8)	>0.9999
Yes	63 (17.7)	12 (18.2)
Tumor size			0.6821
T1-T2	313	57
T3-T4	42	9
Cervical node metastasis			0.2457
N0	296 (83.4)	50 (75.8)
N1	35 (9.6)	11 (16.7)
N2	24(7.0)	5 (7.5)
Type of reconstruction			0.0002*
Local flap	283 (79.7)	37 (56.1)
Pedicled flap	38 (10.7)	17 (25.8)
Free flap	34 (9.6)	12 (18.1)
Cancer subsites			0.0390*
Oral cavity	304	61
Oropharynx	9	4
Larynx	7	0
Salivary Gland	35	1

Notes: *P < 0.05.

Abbreviations: UR, unplanned reoperation; BMI, body mass index.

Table 3

Multivariate analysis of potential influencing factors for UR

Variable	Multivariate survival analysis
	Hazard ratio	95% CI	p-value
Gender	0.997	0.616-1.613	0.991
Smoking	1.180	0.424-3.286	0.751
Alcohol use	0.722	0.242-2.154	0.559
BMI (kg/m2)	1.282	0.751-2.189	0.362
Hypertension	1.519	0.792-2.914	0.208
Age	0.550	0.036-8.385	0.667
Diabetes	2.544	1.257-5.128	0.009*
Preoperative anemia	0.643	0.374-1.104	0.109
Tumor size	1.879	1.038-3.401	0.037*
Cervical nodal metastasis
N0
N1	2.277	0.918-5.649	0.076
N2	3.076	1.526-6.211	0.002*
Type of reconstruction
Local flap	Ref
Pedicled flap	0.491	0.259-0.931	0.029*
Free flap	0.399	0.151-1.055	0.064
Cancer subsites
Oral cavity	Ref
Oropharynx	0.591	0.059-5.927	0.655
Salivary Gland	0.738	0.780-7.004	0.791

Note: *P < 0.05

Abbreviations: UR, unplanned reoperation; BMI, body mass index.

Table 4

Early surgical outcomes for patients with or without UR

Parameters	Non-UR group (n=355)	UR group (n=66)	P-value
Hospital stay (days)	13.24±0.32	23.78±0.82	<0.001*
Postoperative complications	23(6.5%)^a	51(77.3%)^b	<0.001*
Mortality rate	0(0.0%)^a	2(3.0%)^b	0.024*

Notes: *P<0.05. ^aParameters in the non-UR group refer to data after the initial operation. ^bParameters in the UR group refer to data after the second operation.

Abbreviation: UR, unplanned reoperation.

Table 5

Prognostic factors for cancer-specific survival after curative oral cancer resection in univariate and multivariable analyses

Variable	Univariate survival analysis			Multivariate survival analysis
	Hazard ratio	95% CI	p-value	Hazard ratio	95% CI	p-value
Gender	0.987	0.633-1.541	0.955
Smoking	0.927	0.446-1.927	0.838
Alcohol use	0.950	0.413-2.186	0.904
BMI (kg/m2)	0.651	0.400-1.060	0.084
Hypertension	1.263	0.780-2.047	0.342
Age	2.312	1.297-4.123	0.005*	3.077	1.664-5.682	<0.001*
Diabetes	2.693	1.583-4.582	<0.001*	1.833	1.091-3.257	0.023*
Preoperative anemia	2.006	1.246-3.229	0.004*	0.678	0.415-1.109	0.121
Tumor size	2.074	1.257-3.421	0.004*	0.638	0.379-1.074	0.091
Cervical nodal metastasis
N0	Ref
N1	4.878	2.873-8.264	<0.001*	4.464	2.551-7.813	<0.001*
N2	2.667	1.300-5.464	0.007*	2.315	1.101-4.878	0.027*
Type of reconstruction
Local flap	Ref
Pedicled flap	0.433	0.257-0.729	0.002*	0.413	0.236-0.722	0.002*
Free flap	0.336	0.148-0.763	0.009*	0.345	0.148-0.801	0.013*
Cancer subsites
Oral cavity	Ref
Oropharynx	1.658	0.605-4.545	0.325
Larynx	1.390	0.254-7.590	0.704
Salivary Gland	1.041	0.116-9.350	0.971
URO	2.768	1.118-6.854	0.028*	2.864	1.181-7.401	0.020*

Note: *P<0.05.

Abbreviations: UR, unplanned reoperation; BMI, body mass index.

No competing interests reported.

Unplanned reoperation after radical surgery for oral cancer：an analysis of risk factors and outcomes

Status:

Version 1

Abstract

Figures

Background

Methods

Materials and Methods

Data collection and definitions

Operative techniques

Follow-up

Statistical analysis

Results

Clinical variables between UR group and non-UR group

Early surgical outcomes of the UR patients

UR as a prognostic factor for long-term survival

Discussion

Conclusion

Abbreviations

Declarations

References

Tables

Additional Declarations

Status:

Version 1